Medidata Solutions Inc (NASDAQ:MDSO) has earned an average recommendation of “Buy” from the thirteen brokerages that are currently covering the firm. One analyst has rated the stock with a sell rating, two have assigned a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $59.78.

Several research analysts have weighed in on the stock. Jefferies Group LLC reiterated an “underperform” rating and issued a $47.00 price objective (up previously from $46.00) on shares of Medidata Solutions in a research note on Thursday, February 16th. Pacific Crest set a $65.00 price objective on shares of Medidata Solutions and gave the company a “buy” rating in a research note on Sunday, December 4th. Zacks Investment Research upgraded shares of Medidata Solutions from a “hold” rating to a “strong-buy” rating and set a $66.00 price objective on the stock in a research note on Wednesday, February 15th. SunTrust Banks, Inc. upgraded shares of Medidata Solutions from a “neutral” rating to a “buy” rating and upped their price objective for the company from $60.00 to $70.00 in a research note on Friday, February 10th. Finally, Needham & Company LLC upped their price objective on shares of Medidata Solutions from $60.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, February 10th.

In related news, Vice Chairman Steven Isaac Hirschfeld sold 10,000 shares of the company’s stock in a transaction on Wednesday, January 25th. The shares were sold at an average price of $50.83, for a total transaction of $508,300.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, President Vries Glen Michael De sold 7,500 shares of the company’s stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $56.05, for a total transaction of $420,375.00. Following the sale, the president now directly owns 934,929 shares of the company’s stock, valued at $52,402,770.45. The disclosure for this sale can be found here. Insiders sold 55,000 shares of company stock valued at $2,927,525 over the last three months. Insiders own 6.70% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Parkwood LLC increased its stake in Medidata Solutions by 3.1% in the third quarter. Parkwood LLC now owns 4,403 shares of the company’s stock valued at $246,000 after buying an additional 133 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its stake in Medidata Solutions by 1.8% in the third quarter. Municipal Employees Retirement System of Michigan now owns 12,720 shares of the company’s stock valued at $709,000 after buying an additional 220 shares in the last quarter. 1st Global Advisors Inc. increased its stake in Medidata Solutions by 8.7% in the third quarter. 1st Global Advisors Inc. now owns 6,313 shares of the company’s stock valued at $352,000 after buying an additional 503 shares in the last quarter. Teachers Advisors LLC increased its stake in Medidata Solutions by 0.6% in the third quarter. Teachers Advisors LLC now owns 98,128 shares of the company’s stock valued at $5,472,000 after buying an additional 556 shares in the last quarter. Finally, Aperio Group LLC increased its stake in Medidata Solutions by 6.0% in the third quarter. Aperio Group LLC now owns 10,758 shares of the company’s stock valued at $600,000 after buying an additional 606 shares in the last quarter. 99.63% of the stock is owned by institutional investors and hedge funds.

Your IP Address:

Shares of Medidata Solutions (NASDAQ:MDSO) opened at 57.43 on Tuesday. The stock has a 50 day moving average of $54.65 and a 200 day moving average of $53.09. The company has a market cap of $3.21 billion, a P/E ratio of 112.61 and a beta of 1.61. Medidata Solutions has a 52-week low of $35.01 and a 52-week high of $58.77.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings data on Thursday, February 9th. The company reported $0.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.26 by $0.07. The firm had revenue of $124.50 million for the quarter, compared to analyst estimates of $124.15 million. Medidata Solutions had a net margin of 6.25% and a return on equity of 10.82%. The company’s revenue for the quarter was up 25.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.27 EPS. On average, equities analysts anticipate that Medidata Solutions will post $1.24 earnings per share for the current fiscal year.

Medidata Solutions Company Profile

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

5 Day Chart for NASDAQ:MDSO

Receive News & Ratings for Medidata Solutions Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc and related companies with MarketBeat.com's FREE daily email newsletter.